Published 16:03 IST, March 25th 2024
Novo Nordisk acquires Cardior Pharmaceuticals for up to $1.1 billion
The acquisition marks a strategic move for Novo Nordisk, aligning with its objective to broaden its portfolio to include treatments for cardiovascular diseases.
Novo Nordisk Cardior Pharmaceuticals acquisition | Image:
Republic
- Listen to this article
- 1 min read
Advertisement
16:03 IST, March 25th 2024